Guiyuan Luo
Papers
2
Total Citations
9
H-Index
2
About
Dr. Guiyuan Luo is a clinician-researcher whose work bridges rare oncologic pathology and health systems efficiency in minimally invasive surgery. Dr. Luo’s primary research areas include retroperitoneal tumors and the cost-effectiveness of robotic surgical platforms. In a landmark 2023 case report, Dr. Luo was the first to describe primary retroperitoneal mucinous cystic tumors of borderline malignancy (PRMC-BM) mimicking a duplex kidney—a diagnostic challenge that had not been previously documented. This contribution, cited 5 times, provides critical guidance for preoperative differentiation and surgical management of these rare neoplasms. Complementing this clinical work, Dr. Luo conducted a retrospective cost analysis of the Da Vinci surgical instrument supply chain, demonstrating strategies to reduce the financial burden of robotic surgery. This study, with 4 citations, offers actionable insights for hospital administrators and surgeons seeking to balance technological adoption with economic sustainability. By addressing both the rare and the routine—from obscure retroperitoneal cysts to everyday supply chain logistics—Dr. Luo’s research exemplifies a dual commitment to advancing surgical knowledge and improving healthcare delivery.
Research Focus
Key Achievements
Top Papers
- 1
- 2